ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 164 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2016. The put-call ratio across all filers is 1.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $680,024 | +6.8% | 19,075 | +38.2% | 0.08% | -23.8% |
| Q2 2023 | $636,779 | +19.7% | 13,804 | +7.4% | 0.10% | -0.9% |
| Q3 2022 | $532,000 | +110.3% | 12,852 | +268.4% | 0.11% | +211.8% |
| Q1 2022 | $253,000 | -69.3% | 3,489 | -59.7% | 0.03% | -70.7% |
| Q2 2021 | $825,000 | +31.0% | 8,651 | -41.3% | 0.12% | +251.5% |
| Q4 2019 | $630,000 | -64.5% | 14,748 | -64.5% | 0.03% | -64.9% |
| Q3 2019 | $1,777,000 | +5126.5% | 41,548 | +13749.3% | 0.09% | +308.7% |
| Q4 2015 | $34,000 | -99.4% | 300 | +200.0% | 0.02% | +475.0% |
| Q3 2014 | $5,660,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iguana Healthcare Management, LLC | 75,000 | $5,084,000 | 2.52% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 1,237,825 | $83,900,000 | 1.18% |
| CAPITAL INTERNATIONAL LTD /CA/ | 206,718 | $14,011,000 | 0.91% |
| Cormorant Asset Management, LP | 75,000 | $5,084,000 | 0.74% |
| Capital International Sarl | 107,450 | $7,283,000 | 0.63% |
| Rock Springs Capital Management LP | 159,750 | $10,828,000 | 0.62% |
| Opus Point Partners Management, LLC | 12,201 | $827,000 | 0.61% |
| Hood River Capital Management LLC | 109,629 | $7,431,000 | 0.56% |
| Aureus Asset Management, LLC | 50,740 | $2,927,000 | 0.51% |
| ROCKEFELLER FINANCIAL SERVICES INC | 374,663 | $25,395,000 | 0.51% |